Oncogene addiction: setting the stage for molecularly targeted cancer therapySreenath V. Sharma(Harvard University), Jeffrey Settleman(Harvard University)Genes & DevelopmentDecember 13, 200710.1101/gad.1609907Cited by 445SaveCiteExport RISWatch citationsRelated PapersEpidermal Growth Factor Receptor Mutants from Human Lung Cancers Exhibit Enhanced Catalytic Activity and Increased Sensitivity to Gefitinib|Cancer Research|2007|191